In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

OBJECTIVES: We investigated the in vitro antimicrobial susceptibilities of clinically important Gram-negative bacteria (GNB) from 16 major teaching hospitals in Taiwan in 2017. MATERIALS AND METHODS: Escherichia coli (n=686) and Klebsiella pneumoniae bloodstream isolates (n=673), non-typhoid Salmone...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Infect Drug Resist
Autors principals: Jean, Shio-Shin, Lu, Min-Chi, Shi, Zhi-Yuan, Tseng, Shu-Hui, Wu, Ting-Shu, Lu, Po-Liang, Shao, Pei-Lan, Ko, Wen-Chien, Wang, Fu-Der, Hsueh, Po-Ren
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6208934/
https://ncbi.nlm.nih.gov/pubmed/30464540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S175679
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars